RIV Capital Reports Second Quarter Fiscal Year 2022 Financial Results
Retrieved on:
Thursday, November 18, 2021
News, Sport, Perception, Hawthorne, Sale, SEDAR, Risk, Phar-Mor, Cannabis, Company, Hand, Partnership, Compliance, MD, Mission statement, CBD, Niagara College, Regulation, BIO, Research, Investment, Federation, Headset, Hawthorne Gardening Company, Scotts, Scotts Miracle-Gro Company, Public opinion, Multimedia, AIF, Convertible, Growth, Security (finance), Drug, Risk management
During the quarter, the Company also received a $6.5 million distribution upon the termination of PharmHouse's proceedings under the Companies' Creditors Arrangement Act (Canada).
Key Points:
- During the quarter, the Company also received a $6.5 million distribution upon the termination of PharmHouse's proceedings under the Companies' Creditors Arrangement Act (Canada).
- The following represents a brief summary of other developments in the RIV Capital portfolio during and subsequent to Q2 2022:
Subsequent to quarter end, RIV Capital entered into an asset purchase agreement with TREC Brands Inc. ("TREC Brands") for the sale of the Company's financial assets in Agripharm. - Although RIV Capital has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended.
- RIV Capital does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.